Kala Bio Inc (KALA)

Feb 05, 2025

Short Interest in KALA BIO, Inc. (NASDAQ:KALA) Rises By 19.1% - MarketBeat

Feb 05, 2025

Jan 30, 2025

KALA stock soars to 52-week high, reaching $8.81 - MSN

Jan 30, 2025

Jan 28, 2025

KALA stock soars to 52-week high, reaching $8.81 By Investing.com - Investing.com Australia

Jan 28, 2025

Jan 27, 2025

ED Attaches ₹79.78 Crore Assets In Sharon Bio-Medicine’s ₹220 Crore Bank Fraud Case - Free Press Journal

Jan 27, 2025

Jan 17, 2025

Ramesh Lal Kala , IND candidate bio : Assets , Total Income , Liabilities , Criminal Cases and other details. - The Hindu

Jan 17, 2025

Jan 10, 2025

KALA BIO Announces $10.75 Million Private Placement Agreement - WilmerHale

Jan 10, 2025

Jan 08, 2025

Kala Bio executive Todd Bazemore sells $15,206 in stock By Investing.com - Investing.com Australia

Jan 08, 2025

Jan 07, 2025

Kala Bio's head of research sells $18,662 in stock - Investing.com India

Jan 07, 2025

Jan 07, 2025

Kala Bio CEO Mark Iwicki sells $44,093 in stock - Investing.com India

Jan 07, 2025

Jan 07, 2025

Kala Bio's chief business officer sells $15,420 in stock By Investing.com - Investing.com South Africa

Jan 07, 2025

Jan 07, 2025

Kala Bio’s chief business officer sells $15,420 in stock By Investing.com - Investing.com Nigeria

Jan 07, 2025

Jan 07, 2025

Kala Bio's head of research sells $18,662 in stock By Investing.com - Investing.com South Africa

Jan 07, 2025

Jan 07, 2025

Kala Bio CFO Mary Reumuth sells $13,016 in company stock By Investing.com - Investing.com Nigeria

Jan 07, 2025

Jan 07, 2025

Kala Bio CFO Mary Reumuth sells $13,016 in company stock - Investing.com

Jan 07, 2025

Jan 07, 2025

Kala Bio's chief business officer sells $15,420 in stock - Investing.com

Jan 07, 2025

Jan 04, 2025

Baker Bros. Advisors LP Increases Stake in Kala Bio Inc - GuruFocus.com

Jan 04, 2025

Jan 01, 2025

Baker Bros. Advisors buys $2 million in Kala Bio shares By Investing.com - Investing.com Australia

Jan 01, 2025

Dec 31, 2024

KALA BIO announces $10.75M private placement - MSN

Dec 31, 2024

Dec 31, 2024

Baker Bros. Advisors buys $2 million in Kala Bio shares - Investing.com

Dec 31, 2024

Dec 31, 2024

Kala Bio raises $10.75 million in private placement By Investing.com - Investing.com Canada

Dec 31, 2024

Dec 31, 2024

KALA BIO Announces Private Placement Agreement with Institutional Investors - Defense World

Dec 31, 2024

Dec 30, 2024

KALA BIO Secures $10.75 Million in Private Placement to Advance Eye Disease Treatments - Tandav Media

Dec 30, 2024

Dec 30, 2024

Kala Bio raises $10.75 million in private placement - Investing.com India

Dec 30, 2024

Dec 30, 2024

KALA Bio Secures $10.75 Million for Eye Disease Treatments: What’s Next for the Biopharma Stock? - Tandav Media

Dec 30, 2024

Dec 30, 2024

KALA BIO Announces $10,750,000 Private Placement - GlobeNewswire

Dec 30, 2024

Dec 30, 2024

Global Engine Group Holding Limited Acquires 22.5% Stake in Corpotech Holdings Limited, a Hong Kong Data Centre Operator - The Manila Times

Dec 30, 2024

Dec 30, 2024

KALA BIO Secures $10.75M Investment from Major Funds, Extends Cash Runway for Key Eye Treatment Trial - StockTitan

Dec 30, 2024

Dec 27, 2024

Exicure joins hands with GPCR Therapeutics for growth in biotech (NASDAQ:XCUR) - Seeking Alpha

Dec 27, 2024

Dec 20, 2024

RBC Capital Downgrades HOOKIPA Pharma (HOOK) - MSN

Dec 20, 2024

Dec 16, 2024

KALA BIO (KALA) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? - Zacks Investment Research

Dec 16, 2024

Dec 16, 2024

PepGen stock down 22% on FDA clinical hold (update) (PEPG:NASDAQ) - Seeking Alpha

Dec 16, 2024

Dec 11, 2024

Tracking Baker Brothers Portfolio – Q3 2024 Update - Seeking Alpha

Dec 11, 2024

Nov 30, 2024

Kala Bio (LTS:0JQ2) EV-to-Revenue : (As of Nov. 30, 2024) - GuruFocus.com

Nov 30, 2024

Nov 27, 2024

KALAKALA BIO, Inc. Latest Stock News & Market Updates - StockTitan

Nov 27, 2024

Nov 27, 2024

FTC Solar Announces Reverse Stock Split - The Manila Times

Nov 27, 2024

Nov 27, 2024

KALA BIO to Present at Piper Sandler Healthcare Conference, Showcasing Eye Disease Pipeline | KALA Stock News - StockTitan

Nov 27, 2024

Nov 27, 2024

KALA BIO to Present at Piper Sandler 36th Annual Healthcare Conference - GlobeNewswire

Nov 27, 2024

Nov 25, 2024

2024 Pharmaceutical Executive APEX Award Winners - Pharmaceutical Executive

Nov 25, 2024

Nov 24, 2024

Kala Pharmaceuticals Announces IND Submission of its MPP-Formulated Loteprednol Etonbonate (LE-MPP) for Post-Cataract Surgery - Marketscreener.com

Nov 24, 2024

Nov 19, 2024

Kala Pharmaceuticals retains stock target with Buy rating on trial progress - Investing.com India

Nov 19, 2024

Nov 19, 2024

60 Degrees Pharmaceuticals’ (SXTP) Neutral Rating Reaffirmed at HC Wainwright - Defense World

Nov 19, 2024

Nov 19, 2024

Walt Disney (NYSE:DIS) Price Target Raised to $130.00 - Defense World

Nov 19, 2024

Nov 19, 2024

KALA BIO’s (KALA) Buy Rating Reaffirmed at HC Wainwright - Defense World

Nov 19, 2024

Nov 15, 2024

ADAR1 Capital Management, LLC Increases Stake in Kala Bio Inc - GuruFocus.com

Nov 15, 2024